Skip to main navigation Skip to search Skip to main content

Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

  • Valerie Pestinger
  • , Matthew Smith
  • , Toju Sillo
  • , John M Findlay
  • , Jean-Francois Laes
  • , Gerald Martin
  • , Gary Middleton
  • , Phillipe Taniere
  • , Andrew D Beggs

Research output: Contribution to journal › Article › peer-review

Abstract

This article was originally published under a [CC BY NC 4.0] license.

Original languageEnglish
Pages (from-to)505
JournalMolecular Diagnosis and Therapy
Volume24
Issue number4
DOIs
Publication statusPublished - Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants'. Together they form a unique fingerprint.

Cite this